Measurable residual disease testing in acute myeloid leukemia: current state, foundational models, and tools for future development

Authors

Institutions

Publication Details

Journal
Cancer and Metastasis Reviews
Published
2026-03-27
DOI
https://doi.org/10.1007/s10555-026-10322-5
Primary Topic
Acute Myeloid Leukemia Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Measurable residual disease testing in acute myeloid leukemia: current state, foundational models, and tools for future development

Ashish Bains, Stephen D. Willis, Sara Small, Joseph Van Galen
Cancer and Metastasis Reviews
Acute Myeloid Leukemia Research
article

Measurable residual disease testing in acute myeloid leukemia: current state, foundational models, and tools for future development

Ashish Bains, Stephen D. Willis, Sara Small, Joseph Van Galen
article en

Abstract

No abstract available for this paper.
Cancer and Metastasis ReviewsVol. 45(2)
Fox Chase Cancer Center (US), Thomas Jefferson University (US), Temple University Health System (US), Temple University (US)
Partnerships for the goals
Openalex Percentile: Top 4%
Acute Myeloid Leukemia Research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.